{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:54:37Z","timestamp":1780646077215,"version":"3.54.1"},"reference-count":57,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Antenatal corticosteroids are an essential component in the management of women at risk for preterm labour. They promote lung maturation and reduce the risk of other preterm neonatal complications. This narrative review discusses the contentious issues and controversies around the optimal use of antenatal corticosteroids and their consequences for both the mother and the neonate. The most recent evidence base is presented.<\/ns4:p>","DOI":"10.12688\/f1000research.20550.1","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T14:30:05Z","timestamp":1585578605000},"page":"219","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Antenatal corticosteroid administration for foetal lung maturation"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-3337","authenticated-orcid":false,"given":"Katie","family":"Wynne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Delbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Addley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","first-page":"515-25","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.","volume":"50","author":"G Liggins","year":"1972","journal-title":"Pediatrics."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"CD004454","DOI":"10.1002\/14651858.CD004454.pub2","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.","author":"D Roberts","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"CD004454","DOI":"10.1002\/14651858.CD004454.pub3","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.","volume":"3","author":"D Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"e183235","DOI":"10.1001\/jamanetworkopen.2018.3235","article-title":"Association of Antenatal Steroid Exposure With Survival Among Infants Receiving Postnatal Life Support at 22 to 25 Weeks' Gestation.","volume":"1","author":"D Ehret","year":"2018","journal-title":"JAMA Netw Open."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"2348-58","DOI":"10.1001\/jama.2011.1752","article-title":"Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.","volume":"306","author":"W Carlo","year":"2011","journal-title":"JAMA."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"j1039","DOI":"10.1136\/bmj.j1039","article-title":"Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: Prospective cohort study.","volume":"356","author":"C Travers","year":"2017","journal-title":"BMJ."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"1311-20","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal Betamethasone for Women at Risk for Late Preterm Delivery.","volume":"374","author":"C Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"e265-72","DOI":"10.1542\/peds.2012-0079","article-title":"Neonatal morbidities and developmental delay in moderately preterm-born children.","volume":"130","author":"J Kerstjens","year":"2012","journal-title":"Pediatrics."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"461.e1-461.e7","DOI":"10.1016\/j.ajog.2017.04.029","article-title":"Assessing the potential impact of extending antenatal steroids to the late preterm period.","volume":"217","author":"V Souter","year":"2017","journal-title":"Am J Obstet Gynecol."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/bmj.38547.416493.06","article-title":"Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: Pragmatic randomised trial.","volume":"331","author":"P Stutchfield","year":"2005","journal-title":"BMJ."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"614-20","DOI":"10.1080\/14767058.2017.1293026","article-title":"Does implementing a regime of dexamethasone before planned cesarean section at term reduce admission with respiratory morbidity to neonatal intensive care unit? A randomized controlled trial.","volume":"31","author":"A Nooh","year":"2018","journal-title":"J Matern Fetal Neonatal Med."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"CD006614","DOI":"10.1002\/14651858.CD006614.pub3","article-title":"Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term.","volume":"8","author":"A Sotiriadis","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"1-6","DOI":"10.1080\/14767058.2018.1535587","article-title":"Evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidity in early-term elective cesarean.","author":"M Mirzamoradi","year":"2019","journal-title":"J Matern Fetal Neonatal Med."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"62-74","DOI":"10.1016\/j.ajog.2018.04.007","article-title":"Antenatal corticosteroids: An assessment of anticipated benefits and potential risks.","volume":"219","author":"A Jobe","year":"2018","journal-title":"Am J Obstet Gynecol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"219.e1-219.e5","DOI":"10.1016\/j.ajog.2010.04.047","article-title":"The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery.","volume":"203","author":"C Gyamfi","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"39-45","DOI":"10.1067\/mcp.2002.120250","article-title":"Pharmacokinetics of betamethasone in twin and singleton pregnancy.","volume":"71","author":"P Ballabh","year":"2002","journal-title":"Clin Pharmacol Ther."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"482.e1-9","DOI":"10.1016\/j.ajog.2016.05.037","article-title":"The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth.","volume":"215","author":"N Melamed","year":"2016","journal-title":"Am J Obstet Gynecol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"329-35","DOI":"10.1016\/j.ijgo.2016.02.016","article-title":"Fetal and neonatal outcomes after term and preterm delivery following betamethasone administration in twin pregnancies.","volume":"134","author":"T Braun","year":"2016","journal-title":"Int J Gynaecol Obstet."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12884-019-2235-5","article-title":"Effects of antenatal corticosteroids in twin neonates with late preterm birth (ACTWIN [Antenatal Corticosteroids in TWIN late preterm neonates] trial): study protocol for a randomized controlled trial.","volume":"19","author":"S Hong","year":"2019","journal-title":"BMC Pregnancy Childbirth."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"77-9","DOI":"10.1136\/bmj.39225.677708.80","article-title":"Decline in effectiveness of antenatal corticosteroids with time to birth: Real or artefact?","volume":"335","author":"S Gates","year":"2007","journal-title":"BMJ."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"CD003935","DOI":"10.1002\/14651858.CD003935.pub4","article-title":"Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.","author":"C Crowther","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1913-9","DOI":"10.1016\/S0140-6736(06)68846-6","article-title":"Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: A randomised controlled trial.","volume":"367","author":"C Crowther","year":"2006","journal-title":"Lancet."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"633-42","DOI":"10.1016\/j.ajog.2006.03.087","article-title":"Single versus weekly courses of antenatal corticosteroids: Evaluation of safety and efficacy.","volume":"195","author":"R Wapner","year":"2006","journal-title":"Am J Obstet Gynecol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"e1002771","DOI":"10.1371\/journal.pmed.1002771","article-title":"Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: An individual participant data meta-analysis.","volume":"16","author":"C Crowther","year":"2019","journal-title":"PLoS Med."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"e1002746","DOI":"10.1371\/journal.pmed.1002746","article-title":"Antenatal corticosteroid therapy (ACT) and size at birth: A population-based analysis using the Finnish Medical Birth Register.","volume":"16","author":"A Rodriguez","year":"2019","journal-title":"PLoS Med."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"37-42","DOI":"10.1016\/j.siny.2018.10.001","article-title":"The place of antenatal corticosteroids in late preterm and early term births.","volume":"24","author":"H Haviv","year":"2019","journal-title":"Semin Fetal Neonatal Med."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"273-7","DOI":"10.1002\/1520-6661(200009\/10)9:5<273::AID-MFM3>3.0.CO;2-N","article-title":"Glucocorticoid-associated maternal hyperglycemia: a randomized trial of insulin prophylaxis.","volume":"9","author":"J Star","year":"2000","journal-title":"J Matern Fetal Med."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"65-74","DOI":"10.1542\/peds.2007-2822","article-title":"Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia.","volume":"122","author":"C Burns","year":"2008","journal-title":"Pediatrics."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"116-26","DOI":"10.1159\/000492859","article-title":"Neonatal Glycaemia and Neurodevelopmental Outcomes: A Systematic Review and Meta-Analysis.","volume":"115","author":"R Shah","year":"2019","journal-title":"Neonatology."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"972-83","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years.","volume":"171","author":"C McKinlay","year":"2017","journal-title":"JAMA Pediatr."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"913-21","DOI":"10.1001\/jamapediatrics.2015.1631","article-title":"Association Between Transient Newborn Hypoglycemia and Fourth-Grade Achievement Test Proficiency: A Population-Based Study.","volume":"169","author":"J Kaiser","year":"2015","journal-title":"JAMA Pediatr."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"e0147604","DOI":"10.1371\/journal.pone.0147604","article-title":"Antenatal Corticosteroids for Reducing Adverse Maternal and Child Outcomes in Special Populations of Women at Risk of Imminent Preterm Birth: A Systematic Review and Meta-Analysis.","volume":"11","author":"R Amiya","year":"2016","journal-title":"PLoS One."},{"key":"ref-33","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.59.OC4.4","article-title":"An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia after betamethasone administration in women with gestational diabetes.","author":"C Rowe","year":"2018","journal-title":"EJEA."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12884-019-2206-x","article-title":"Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE).","volume":"19","author":"T Schmitz","year":"2019","journal-title":"BMC Pregnancy Childbirth."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"1856-62","DOI":"10.1016\/S0140-6736(05)66617-2","article-title":"Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial.","volume":"365","author":"S Dalziel","year":"2005","journal-title":"Lancet."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bmj.38576.494363.E0","article-title":"Antenatal exposure to betamethasone: Psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial.","volume":"331","author":"S Dalziel","year":"2005","journal-title":"BMJ."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"F195-200","DOI":"10.1136\/archdischild-2012-303157","article-title":"Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial).","volume":"98","author":"P Stutchfield","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"3538-44","DOI":"10.1210\/jc.2012-1970","article-title":"Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children.","volume":"97","author":"N Alexander","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"278-85","DOI":"10.1016\/j.psyneuen.2016.09.021","article-title":"Prenatal betamethasone exposure and psychopathology risk in extremely low birth weight survivors in the third and fourth decades of life.","volume":"74","author":"C Savoy","year":"2016","journal-title":"Psychoneuroendocrinology."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"1179-89","DOI":"10.1056\/NEJMoa071152","article-title":"Outcomes at 2 years of age after repeat doses of antenatal corticosteroids.","volume":"357","author":"C Crowther","year":"2007","journal-title":"N Engl J Med."},{"key":"ref-41","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0947","article-title":"Mid-Childhood Outcomes of Repeat Antenatal Corticosteroids: A Randomized Controlled Trial.","volume":"138","author":"C Crowther","year":"2016","journal-title":"Pediatrics."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"e405-15","DOI":"10.1542\/peds.2014-2408","article-title":"Cardiovascular risk factors in children after repeat doses of antenatal glucocorticoids: an RCT.","volume":"135","author":"C McKinlay","year":"2015","journal-title":"Pediatrics."},{"key":"ref-43","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-4250","article-title":"Mid-Childhood Bone Mass After Exposure to Repeat Doses of Antenatal Glucocorticoids: A Randomized Trial.","volume":"139","author":"C McKinlay","year":"2017","journal-title":"Pediatrics."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"1190-8","DOI":"10.1056\/NEJMoa071453","article-title":"Long-term outcomes after repeat doses of antenatal corticosteroids.","volume":"357","author":"R Wapner","year":"2007","journal-title":"N Engl J Med."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"301.e1-301.e16","DOI":"10.1016\/j.ajog.2018.05.007","article-title":"The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy.","volume":"219","author":"M Kemp","year":"2018","journal-title":"Am J Obstet Gynecol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"98-104","DOI":"10.1016\/j.diabres.2016.06.005","article-title":"Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes.","volume":"118","author":"J Jolley","year":"2016","journal-title":"Diabetes Res Clin Pract."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2393-13-104","article-title":"Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol.","volume":"13","author":"C Crowther","year":"2013","journal-title":"BMC Pregnancy Childbirth."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"274-81","DOI":"10.1097\/01.AOG.0000110249.84858.90","article-title":"Single versus weekly courses of antenatal corticosteroids in preterm premature rupture of membranes.","volume":"103","author":"M Lee","year":"2004","journal-title":"Obstet Gynecol."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"999-1003","DOI":"10.1097\/AOG.0000000000000460","article-title":"Preterm premature rupture of membranes and the rate of neonatal sepsis after two courses of antenatal corticosteroids.","volume":"124","author":"C Gyamfi-Bannerman","year":"2014","journal-title":"Obstet Gynecol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"537-44","DOI":"10.1055\/s-0034-1396690","article-title":"Antenatal corticosteroids for preterm premature rupture of membranes: single or repeat course?","volume":"32","author":"K Brookfield","year":"2015","journal-title":"Am J Perinatol."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"113-22","DOI":"10.1111\/j.1471-0528.2010.02751.x","article-title":"Antenatal steroids and neonatal outcome after chorioamnionitis: A meta-analysis.","volume":"118","author":"J Been","year":"2011","journal-title":"BJOG."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"288-96","DOI":"10.1097\/AOG.0000000000000629","article-title":"Trends in Optimal, Suboptimal, and Questionably Appropriate Receipt of Antenatal Corticosteroid Prophylaxis.","volume":"125","author":"N Razaz","year":"2015","journal-title":"Obstet Gynecol."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"591-7","DOI":"10.1111\/aogs.13301","article-title":"Antenatal corticosteroids: a retrospective cohort study on timing, indications and neonatal outcome.","volume":"97","author":"J Fr\u00e4ndberg","year":"2018","journal-title":"Acta Obstet Gynecol Scand."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"101-6","DOI":"10.1046\/j.0004-8666.2003.00052.x","article-title":"Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review.","volume":"43","author":"K McLaughlin","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"643-50","DOI":"10.1111\/ajo.12657","article-title":"Trends in receipt of single and repeat courses of antenatal corticosteroid administration among preterm and term births: A retrospective cohort study.","volume":"57","author":"L Grzeskowiak","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"352-5","DOI":"10.1002\/ijgo.12746","article-title":"Good clinical practice advice: Antenatal corticosteroids for fetal lung maturation.","volume":"144","year":"2019","journal-title":"Int J Gynaecol Obstet."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"629-39","DOI":"10.1016\/S0140-6736(14)61651-2","article-title":"A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: The ACT cluster-randomised trial.","volume":"385","author":"F Althabe","year":"2015","journal-title":"Lancet."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-219\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-219\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-219\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T23:48:39Z","timestamp":1666223319000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-219\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":57,"URL":"https:\/\/doi.org\/10.12688\/f1000research.20550.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.22590.r61815","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.22590.r61814","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-219\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.22590.r61815, Suhas G Kallapur, Divisions of Neonatology and Developmental Biology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA, 30 Mar 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-219\/v1#referee-response-61815","order":0,"name":"referee-response-61815","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.22590.r61814, Karen E Chapman, University\/BHF Centre for Cardiovascular Science, The University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, UK, 30 Mar 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-219\/v1#referee-response-61814","order":1,"name":"referee-response-61814","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication).","order":0,"name":"copyright-info","label":"Copyright"}]}}